HeLa UI/ DE000A0MUQ48 /
NAV2024-06-10 | Chg.+0.2800 | Type of yield | Investment Focus | Investment company |
---|---|---|---|---|
196.6000EUR | +0.14% | paying dividend | Mixed Fund Worldwide | Universal-Investment ▶ |
GlobeNewswire
04-22
Excision BioTherapeutics to Present Positive Data from its HSV-1 Keratitis Program, EBT-104, at the ...
GlobeNewswire
2023-10-24
MeiraGTx Announces an Oral Presentation and Eight Posters at the European Society of Gene and Cell T...
GlobeNewswire
2021-11-03
Solid Biosciences Provides Third Quarter 2021 Business Update and Financial Results
GlobeNewswire
2021-08-16
Solid Biosciences Provides Second Quarter 2021 Business Update and Financial Results
GlobeNewswire
2021-08-02
Ultragenyx Reports Second Quarter 2021 Financial Results and Corporate Update
GlobeNewswire
2021-05-14
Ultragenyx Announces Positive Multi-Year Durability Data from Ongoing Phase 1/2 Gene Therapy Studies...
GlobeNewswire
2021-05-14
Solid Biosciences Provides First Quarter 2021 Business Update and Financial Results
GlobeNewswire
2021-05-04
Ultragenyx Reports First Quarter 2021 Financial Results and Corporate Update
GlobeNewswire
2021-04-27
Ultragenyx Announces Upcoming Data Presentations at American Society of Gene & Cell Therapy 2021 Vir...
GlobeNewswire
2021-01-21
Ultragenyx Announces FDA Clearance of Investigational New Drug (IND) Application for UX701, a New Ge...
GlobeNewswire
2021-01-08
Ultragenyx Announces Progress Across Broad Gene Therapy Portfolio and Positive Longer-Term Data from...
GlobeNewswire
2020-11-09
Ultragenyx Announces Plans to Build Large-scale Gene Therapy Manufacturing Facility to Support Pipel...
GlobeNewswire
2020-11-05
Solid Biosciences Reports Third Quarter 2020 Financial Results and Provides Business Update
GlobeNewswire
2020-10-27
Ultragenyx Reports Third Quarter 2020 Financial Results and Corporate Update
GlobeNewswire
2020-10-23
Ultragenyx and Solid Biosciences Announce Strategic Collaboration to Develop and Commercialize New G...
GlobeNewswire
2020-07-30
Ultragenyx Reports Second Quarter 2020 Financial Results and Corporate Update
GlobeNewswire
2020-05-06
Ultragenyx Reports First Quarter 2020 Financial Results and Corporate Update
GlobeNewswire
2020-04-29
Ultragenyx Announces Upcoming Data Presentations at American Society of Gene & Cell Therapy 2020 Vir...
GlobeNewswire
2020-04-01
Ultragenyx Enters into Strategic Partnership with Daiichi Sankyo for Gene Therapy Manufacturing Tech...
GlobeNewswire
2020-02-13
Ultragenyx Reports Fourth Quarter and Full Year 2019 Financial Results and Corporate Update
GlobeNewswire
2020-01-13
Ultragenyx Reports Preliminary 2019 Revenue and Provides 2020 Crysvita Revenue Guidance